This week has laid bare the fundamental tensions reshaping the global semiconductor and artificial intelligence industry. As legislative threats target one pillar of the ecosystem, other giants are mobilizing unprecedented capital and forging new alliances, painting a picture of a sector navigating between geopolitical constraints and technological ambition.
Legislative Pressure Mounts for ASML
A proposed U.S. bill, the MATCH Act, poses a significant new challenge for ASML. Bipartisan lawmakers are seeking to prohibit the Dutch firm from selling even its older deep ultraviolet (DUV) lithography systems to China, including the maintenance contracts for already installed machines. This move would extend far beyond existing export controls, which already ban extreme ultraviolet (EUV) machine sales.
ASML’s shares declined to 1,135.40 euros on Wednesday from a previous close of 1,187.60 euros following the draft’s publication. Such a ban would effectively force ASML to break existing contracts with Chinese clients. The region represented 33% of the company’s revenue in 2025, with management already anticipating a drop to approximately 20% for 2026.
- Revenue (TTM): $37.7 billion
- Gross Margin: 52.8%
- Net Margin: 28.8%
- Analyst Consensus: 37 buy recommendations, 1 sell recommendation, average price target of 1,407.56 euros
The upcoming quarterly report on April 15th will serve as a critical test, requiring management to publicly address the MATCH Act’s potential revenue impact for the first time. Most analysts retain confidence, citing exploding AI demand for High-NA EUV systems needed for 2nm and 1.4nm chips as a medium-term counterbalance to any loss in China.
AMD Achieves Benchmark Breakthrough
AMD seized the spotlight this week with a technical milestone. In the latest MLPerf Inference 6.0 benchmarks—the industry’s most comprehensive update—AMD surpassed one million tokens per second in multi-node inference operations for the first time.
The company’s Instinct MI355X accelerators demonstrated optimized FP4 performance on large language models, posted initial results in new GPT-OSS-120B and Wan2.2 benchmarks, and showcased distributed inference across up to twelve nodes. While Nvidia secured wins in new categories using its Blackwell Ultra hardware, the key takeaway was software optimization: AMD achieved significant performance leaps on existing hardware, supported by results submitted from nine ecosystem partners.
Market experts responded swiftly. Erste Group upgraded AMD from “Hold” to “Buy” on April 2, with Wells Fargo praising the progress a day earlier. The consensus among 33 analysts is a price target of $261.21, roughly 20% above the current trading level.
- Market Capitalization: $329.3 billion
- Quarter-over-Quarter Revenue Growth: +34.1%
- 2026 Revenue Forecast: $46.9 billion
- 2027 Revenue Forecast: $66.9 billion (+42.6%)
With its MI400 series on CDNA 5 architecture and Helios rack-scale solution announced for 2026, AMD aims to maintain an annual product cycle. The benchmark leadership in tokens per second must now translate into concrete customer wins against Nvidia’s dominant ecosystem.
Infineon Gains from AI’s Power Demand
Infineon traded at 38.96 euros, well below its 52-week high of 48.23 euros but receiving fresh support. JPMorgan upgraded the stock to “Overweight,” raising its price target from 40 to 48 euros. The rationale centers on Infineon’s growing role as a power supplier for AI infrastructure.
The timing aligns with a customer communication from Infineon noting that rapid AI data center expansion is causing shortages for certain products, with new prices effective since April 1. JPMorgan emphasized that scarcity for AI-optimized MOSFETs is now spilling over to non-AI products, granting Infineon pricing power across its Power & Sensor Systems division.
Its forward P/E ratio stands at 17.04—a significant discount to the trailing P/E of 48.23, signaling the market is pricing in substantial earnings growth. Bernstein Research highlighted Infineon’s 32% market share in automotive microcontrollers and 29% in power semiconductors. The next quarterly report on May 6 will reveal whether AI-related price increases can offset persistent softness in the automotive segment.
Should investors sell immediately? Or is it worth buying Asml?
IBM Forges Dual Strategic Paths
IBM is placing long-term strategic bets. Within 48 hours, the company announced two starkly different partnerships, both targeting the future of enterprise AI.
On April 2, IBM revealed a collaboration with Arm to develop dual-architecture hardware, aiming to provide businesses greater flexibility for AI and data-intensive workloads. This cooperation complements IBM’s own Telum II processors and Spyre accelerators with Arm-based designs, a move likely to resonate with large corporate and government clients.
Just a day earlier, on March 31, IBM and ETH Zurich announced a ten-year research partnership. The focus is on algorithms at the intersection of AI and quantum computing, specifically targeting optimization problems, differential equations, linear algebra, and complex systems modeling. IBM will fund new professorships at ETH.
IBM’s stock closed at $243.14 on April 1, about 12.5% below its 200-day moving average and 25% under its 52-week high. Both partnerships are long-term wagers whose returns the market struggles to price in the short term, a challenge compounded by IBM’s already elevated debt levels.
SoftBank’s High-Stakes OpenAI Bet
SoftBank has transferred the first of three planned payments to OpenAI. On April 1, $10 billion was wired via Vision Fund 2, financed by a bridge loan secured in late March. At an exchange rate of 158.87 yen per dollar, this equates to approximately 1.589 trillion yen.
The market reacted with skepticism. SoftBank’s ADRs (SFTBY) fell 6.5% to $11.17 on April 2. Concerns are evident: a new unsecured 40 billion dollar loan with a twelve-month term is funding a total investment of $30 billion in OpenAI. The second and third tranches are scheduled for July and October.
This commitment pushes SoftBank’s total investment in OpenAI past the $60 billion mark. Its P/E ratio of 5.23 appears optically cheap but reflects massive leverage. The analyst consensus is “Hold,” with three buy recommendations facing two hold and one sell recommendation.
The bridge loan’s twelve-month maturity coincides with speculation about a potential OpenAI IPO in late 2026 or early 2027. SoftBank reports quarterly figures on May 7, at which point the market will scrutinize the financing structure in detail.
A Sector Defining Its Future
The narratives across these five companies reveal three defining fracture lines within the sector:
- Geopolitical Risk: ASML bears the brunt, facing a potential ban covering both new sales and maintenance of installed DUV tools. Infineon experiences a milder variant, where price increases for power semiconductors disproportionately affect smaller Chinese buyers.
- The Benchmark Arms Race: AMD used MLPerf 6.0 as a stage to demonstrate the commercial maturity of its ecosystem, with software optimization becoming a critical differentiator against Nvidia’s hardware lead.
- Capital Deployment Under Scrutiny: SoftBank’s $30 billion wager on OpenAI represents the sector’s most aggressive positioning. IBM’s partnerships with Arm and ETH Zurich pursue the opposite strategy—long-term, research-driven, and difficult to value.
The next 30 days will bring clarity on multiple fronts. ASML’s April 15 report will gauge regulatory impact, Infineon’s May 6 results must substantiate AI-driven pricing power, and AMD needs to convert benchmark wins into market share. IBM’s alliances require visible use cases, while SoftBank’s stock remains a leveraged proxy on OpenAI’s success. The sector is caught between technological breakthrough and geopolitical narrowing—an equilibrium unlikely to be found this quarter.
Ad
Asml Stock: Buy or Sell?! New Asml Analysis from April 4 delivers the answer:
The latest Asml figures speak for themselves: Urgent action needed for Asml investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 4.
Asml: Buy or sell? Read more here...









